BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38112671)

  • 41. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
    Lovett SM; Sandler DP; O'Brien KM
    J Natl Cancer Inst; 2023 Jun; 115(6):662-670. PubMed ID: 36806439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary fat intake and risk of non-Hodgkin lymphoma in 2 large prospective cohorts.
    Bertrand KA; Giovannucci E; Rosner BA; Zhang SM; Laden F; Birmann BM
    Am J Clin Nutr; 2017 Aug; 106(2):650-656. PubMed ID: 28659300
    [No Abstract]   [Full Text] [Related]  

  • 44. Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study.
    Koch T; Jørgensen JT; Christensen J; Dehlendorff C; Priskorn L; Simonsen MK; Duun-Henriksen AK; Andersen ZJ; Juul A; Bräuner EV; Hickey M
    Int J Cancer; 2021 Aug; 149(3):585-593. PubMed ID: 33729548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occupational risk factors for subgroups of non-Hodgkin's lymphoma.
    Tatham L; Tolbert P; Kjeldsberg C
    Epidemiology; 1997 Sep; 8(5):551-8. PubMed ID: 9270958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hysterectomy With and Without Oophorectomy, Tubal Ligation, and Risk of Cardiovascular Disease in the Nurses' Health Study II.
    Farland LV; Rice MS; Degnan WJ; Rexrode KM; Manson JE; Rimm EB; Rich-Edwards J; Stewart EA; Cohen Rassier SL; Robinson WR; Missmer SA
    J Womens Health (Larchmt); 2023 Jul; 32(7):747-756. PubMed ID: 37155739
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Level of education and the risk of lymphoma in the European prospective investigation into cancer and nutrition.
    Hermann S; Rohrmann S; Linseisen J; Nieters A; Khan A; Gallo V; Overvad K; Tjønneland A; Raaschou-Nielsen O; Bergmann MM; Boeing H; Becker N; Kaaks R; Bueno-de-Mesquita HB; May AM; Vermeulen RC; Bingham S; Khaw KT; Key TJ; Travis RC; Trichopoulou A; Georgila C; Triantafylou D; Celentano E; Krogh V; Masala G; Tumino R; Agudo A; Altzibar JM; Ardanaz E; Martínez-García C; Suárez MV; Tormo MJ; Braaten T; Lund E; Manjer J; Zackrisson S; Hallmans G; Malmer B; Boffetta P; Brennan P; Slimani N; Vineis P; Riboli E
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):71-7. PubMed ID: 19582474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pigmentary traits, sun exposure, and risk of non-Hodgkin's lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort.
    Garcin LM; Gelot A; Gomez RR; Gusto G; Boutron-Ruault MC; Kvaskoff M; Severi G; Besson C
    Cancer Med; 2021 Jan; 10(1):297-304. PubMed ID: 33219744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parity, Age at First Birth, and Risk of Death from Non-Hodgkin's Lymphoma: A Population-Based Cohort Study in Taiwan.
    Chen BK; Yang CY
    Int J Environ Res Public Health; 2015 Aug; 12(8):9131-40. PubMed ID: 26251917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
    Willett EV; Morton LM; Hartge P; Becker N; Bernstein L; Boffetta P; Bracci P; Cerhan J; Chiu BC; Cocco P; Dal Maso L; Davis S; De Sanjose S; Smedby KE; Ennas MG; Foretova L; Holly EA; La Vecchia C; Matsuo K; Maynadie M; Melbye M; Negri E; Nieters A; Severson R; Slager SL; Spinelli JJ; Staines A; Talamini R; Vornanen M; Weisenburger DD; Roman E;
    Int J Cancer; 2008 May; 122(9):2062-70. PubMed ID: 18167059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Britton JA; Khan AE; Rohrmann S; Becker N; Linseisen J; Nieters A; Kaaks R; Tjønneland A; Halkjaer J; Severinsen MT; Overvad K; Pischon T; Boeing H; Trichopoulou A; Kalapothaki V; Trichopoulos D; Mattiello A; Tagliabue G; Sacerdote C; Peeters PH; Bueno-de-Mesquita HB; Ardanaz E; Navarro C; Jakszyn P; Altzibar JM; Hallmans G; Malmer B; Berglund G; Manjer J; Allen N; Key T; Bingham S; Besson H; Ferrari P; Jenab M; Boffetta P; Vineis P; Riboli E
    Haematologica; 2008 Nov; 93(11):1666-77. PubMed ID: 18835833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of Non-Hodgkin's Lymphoma.
    Thandra KC; Barsouk A; Saginala K; Padala SA; Barsouk A; Rawla P
    Med Sci (Basel); 2021 Jan; 9(1):. PubMed ID: 33573146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinicopathological features and prognostic analysis of 151 patients with primary extra-nodal non-Hodgkin's lymphoma].
    Wang C; Yuan C; He H; Bai O
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):858-62. PubMed ID: 25620485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
    Mitarnun W; Suwiwat S; Pradutkanchana J
    Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.